Edesa Biotech
EDSA
17 hedge funds and large institutions have $241K invested in Edesa Biotech in 2018 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
350% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 2
226% more capital invested
Capital invested by funds: $74K → $241K (+$167K)
70% more funds holding
Funds holding: 10 → 17 (+7)
0.06% more ownership
Funds ownership: 0.02% → 0.08% (+0.06%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$71.1K |
| 2 |
Jane Street
New York
|
+$31K |
| 3 |
Renaissance Technologies
New York
|
+$29.9K |
| 4 |
Millennium Management
New York
|
+$25.7K |
| 5 |
VF
Virtu Financial
New York
|
+$24.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$10.3K |
| 2 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$446 |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$127 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $65K | +$71.1K | +1,116 | New |
|
|
TSS
2
Two Sigma Securities
New York
| $28K | +$8.66K | +136 | +39% |
|
|
3
Jane Street
New York
| $28K | +$31K | +487 | New |
|
|
4
Renaissance Technologies
New York
| $27K | +$29.9K | +469 | New |
|
|
5
Millennium Management
New York
| $24K | +$25.7K | +403 | New |
|
|
VF
6
Virtu Financial
New York
| $23K | +$24.8K | +389 | New |
|
|
RJFSA
7
Raymond James Financial Services Advisors
St. Petersburg,
Florida
| $21K | – | – | – |
|
8
Goldman Sachs
New York
| $17K | +$18.9K | +297 | New |
|
|
9
UBS Group
Zurich,
Switzerland
| $5K | -$10.3K | -162 | -66% |
|
|
AG
10
Advisor Group
Phoenix,
Arizona
| $2K | – | – | – |
|
11
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $1K | +$764 | +12 | New |
|
|
LTFS
12
Ladenburg Thalmann Financial Services
Miami,
Florida
| – | -$446 | -7 | -88% |
|
|
13
Bank of America
Charlotte,
North Carolina
| – | -$127 | -2 | Closed |
|
|
RFC
14
Regions Financial Corp
Birmingham,
Alabama
| – | +$64 | +1 | New |
|
|
WAS
15
WESPAC Advisors SoCal
Pasadena,
California
| – | +$446 | +7 | New |
|
EDSA Hedge Fund Activity: Q3 2018 in Review
17 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q3 2018, worth a combined $241K — up 226% from $74K a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new EDSA positions and 2 closed out — a net gain of 7 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $71.1K. The largest seller was UBS Group, cutting an estimated $10.3K.
- 17 institutional investors held Edesa Biotech (EDSA) as of Q3 2018, up from 10 in Q2 2018.
- Funds reported $241K of Edesa Biotech stock for Q3 2018, up 226% quarter-over-quarter.
- 9 funds opened new Edesa Biotech positions in Q3 2018 and 2 closed out, a net change of +7 holders.
- The largest Edesa Biotech buyer in Q3 2018 was Sabby Management, an estimated $71.1K added.
- The largest Edesa Biotech seller in Q3 2018 was UBS Group, an estimated $10.3K sold.
Based on aggregated 13F filings for Q3 2018.